An in vivo neovascularization assay for screening regulators of angiogenesis and assessing their effects on pre-existing vessels

Angiogenesis

Volumn 15, Issue 4, 2012, Pages 643-655

  Kilarski, Witold W ^a   Petersson, Ludvig ^b   Fuchs, Peder Fredlund ^b   Zielinski, Marcin S ^a   Gerwins, Pär ^b  

^a EPFL   (Switzerland)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; Animal model; Chick chorioallantoic membrane; Drug screening; In vivo; Tumor; Wound healing

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; COLLAGEN TYPE 1; FIBRIN; FIBROBLAST GROWTH FACTOR 2; FUMAGILLIN; HYDROCORTISONE; NYLON; PLATELET DERIVED GROWTH FACTOR BB; THALIDOMIDE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A; WORTMANNIN;

ANGIOGENESIS; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL DENSITY; BLOOD VESSEL INJURY; BLOOD VESSEL PARAMETERS; BLOOD VESSEL PERMEABILITY; CHICK; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG SCREENING; IMAGE ANALYSIS; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

ANIMALIA;

EID: 84875056626     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9287-8     Document Type: Article

References (58)

1. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315(26):1650-1659. (Pubitemid 17052899)
2. Rogers PA, Gargett CE (1998) Endometrial angiogenesis. Angiogenesis 2(4):287-294. (Pubitemid 128514256)
3. Tonnesen MG, Feng X, Clark RA (2000) Angiogenesis in wound healing. J Investig Dermatol Symp Proc 5(1):40-46. (Pubitemid 32044088)
4. Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298-307.
5. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3(6):401-410. (Pubitemid 37328844)
6. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180(3):1141-1146. (Pubitemid 24256627)
7. Virag JI, Murry CE (2003) Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 163(6):2433-2440. (Pubitemid 37466484)
8. Beohar N, Rapp J, Pandya S, Losordo DW (2010) Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol 56(16):1287-1297. doi:10.1016/j.jacc. 2010.05.039.
9. Jain RK, Duda DG, Clark JW, Loeffler JS (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 3(1):24-40. (Pubitemid 43108832)
10. Augustin HG (1998) Antiangiogenic tumour therapy: will it work? Trends Pharmacol Sci 19(6):216-222. (Pubitemid 28312166)
11. Kerbel R, Folkman J (2002) Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2(10):727-739. (Pubitemid 37328908)
12. Holstein SA, Hohl RJ (2012) Therapeutic additions and possible deletions in oncology in 2011. Clin Pharmacol Ther 91:15-17. doi:10.1038/clpt.2011.288.
13. Rice JJ, Gerwins P, Kilarski WW (2012) Mechanisms of tumor therapies angiogenesis: perspectives from antiangiogenic tumor therapies. Curr Angiogenesis 1(4):139-147.
14. Sparano JA, Bernardo P, Stephenson P, Gradishar WJ, Ingle JN, Zucker S, Davidson NE (2004) Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196. J Clin Oncol 22:4683-4690. doi:10.1200/JCO.2004.08.054. (Pubitemid 41185077)
15. Krüger A, Soeltl R, Sopov I, Soeltl R, Sopov I, Kopitz C, Arlt M, Magdolen V, Harbeck N (2001) Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis advances in brief hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes. Cancer 1272-1275.
16. Lu C, Lee JJ, Komaki R, Herbst RS, Feng L, Evans WK, Choy H, Desjardins P, Esparaz BT, Truong MT, Saxman S, Kelaghan J, Bleyer A, Fisch MJ (2010) Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial. J Natl Cancer Inst 102:859-865. doi:10.1093/jnci/djq179.
17. Reynolds AR, Hart IR, Watson AR, Welti JC, Silva RG, Robinson SD, Da Violante G, Gourlaouen M, Salih M, Jones MC, Jones DT, Saunders G, Kostourou V, Perron-Sierra F, Norman JC, Tucker GC, Hodivala-Dilke KM (2009) Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat Med 15:392-400. doi:10.1038/nm.1941.
18. Weis SM, Stupack DG, Cheresh DA (2009) Agonizing integrin antagonists? Cancer Cell 15:359-361. doi:10.1016/j.ccr.2009. 04.005.
19. Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N (2003) Angiogenesis assays: a critical overview. Clin Chem 49(1):32-40. (Pubitemid 36078551)
20. Jain RK, Schlenger K, Hockel M, Yuan F (1997) Quantitative angiogenesis assays: progress and problems. Nat Med 3(11): 1203-1208. (Pubitemid 27508819)
21. Kilarski WW, Bikfalvi A (2007) Recent developments in tumor angiogenesis. Curr Pharm Biotechnol 8(1):3-9. (Pubitemid 46322258)
22. Staton CA, Reed MW, Brown NJ (2009) A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol 90(3):195-221.
23. Hasan J, Shnyder SD, Bibby M, Double JA, Bicknel R, Jayson GC (2004) Quantitative angiogenesis assays in vivo-a review. Angiogenesis 7(1):1-16. (Pubitemid 39127766)
24. Ribatti D (2008) Erythropoietin, the first century. Leuk Res 32(8):1169-1172. doi:10.1016/j.leukres.2008.01.018.
25. Djonov V, Schmid M(2000) Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res 86(3):286-292. (Pubitemid 30108822)
26. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6):1163-1177. (Pubitemid 36870177)
27. Isogai S, Lawson ND, Torrealday S, Horiguchi M, Weinstein BM (2003) Angiogenic network formation in the developing vertebrate trunk. Development 130(21):5281-5290. (Pubitemid 37369685)
28. Risau W (1997) Mechanisms of angiogenesis. Nature 386(6626): 671-674. (Pubitemid 27193480)
29. Beerepoot LV, Witteveen EO, Groenewegen G, Beerepoot LV, Witteveen EO, Groenewegen G, Fogler WE, Sim BKL, Sidor C, Zonnenberg BA, Schramel F, Gebbink MFBG, Voest EE (2003) Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study. Clin Cancer Res 9(11):4025-4033. (Pubitemid 37204017)
30. Borges J, Tegtmeier FT, Padron NT, Mueller MC, Lang EM, Stark GB (2003) Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Eng 9(3):441-450. (Pubitemid 36736127)
31. Kilarski WW, Jura N, Gerwins P (2003) Inactivation of Src family kinases inhibits angiogenesis in vivo: implications for a mechanism involving organization of the actin cytoskeleton. Exp Cell Res 291(1):70-82. (Pubitemid 37338684)
32. Nguyen M, Shing Y, Folkman J (1994) Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 47(1):31-40. (Pubitemid 24194854)
33. Algire GH, Legallais FY (1952) Microscopic studies on tumor histo-physiology in transparent chambers in mice. Acta Unio Int Contra Cancrum 7(5):759-760.
34. Clark ER, Clark EL (1939) Microscopic observations of the growth of blood capillaries in the living mammal. Am J Anat 64: 251-299.
35. Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 93(25):14765-14770. (Pubitemid 26419043)
36. Gimbrone MA Jr, Cotran RS, Leapman SB, Folkman J (1974) Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 52(2):413-427.
37. Cursiefen C, Ikeda S, Nishina PM, Smith RS, Ikeda A, Jackson D, Mo JS, Chen L, Dana MR, Pytowski B, Kruse FE, Streilein JW (2005) Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling. Am J Pathol 166(5):1367-1377. doi:10.1016/S0002-9440(10)62355-3. (Pubitemid 40586508)
38. Isaji M, Miyata H, Ajisawa Y, Takehana Y, Yoshimura N (1997) Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br J Pharmacol 122(6):1061-1066. (Pubitemid 27494219)
39. Hagedorn M, Balke M, Schmidt A, Bloch W, Kurz H, Javerzat S, Rousseau B, Wilting J, Bikfalvi A (2004) VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis. Dev Dyn 230(1):23-33. (Pubitemid 38544070)
40. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176(5):1375-1379.
41. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348(6301): 555-557. doi:10.1038/348555a0. (Pubitemid 120015110)
42. Liu LZ, Li C, Chen Q, Jing Y, Carpenter R, Jiang Y, Kung HF, Lai L, Jiang BH (2011) MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS One 6(4):e19139. doi:10.1371/journal.pone.0019139.
43. D'Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91(9):4082-4085. (Pubitemid 24139577)
44. Oikawa T, Shimamura M (1996) Potent inhibition of angiogenesis by wortmannin, a fungal metabolite. Eur J Pharmacol 318(1): 93-96. doi:S0014-2999(96)00864-3. (Pubitemid 27033209)
45. Li WW, Casey R, Gonzalez EM, Folkman J (1991) Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization. Invest Ophthalmol Vis Sci 32(11):2898-2905.
46. Kilarski WW, Samolov B, Petersson L, Kvanta A, Gerwins P (2009) Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med 15(6):657-664.
47. Seandel M, Noack-Kunnmann K, Zhu D, Aimes RT, Quigley JP (2001) Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Blood 97(8):2323- 2332. (Pubitemid 32291478)
48. Ribatti D, Nico B, Vacca A, Presta M (2006) The gelatin spongechorioallantoic membrane assay. Nat Protocols 1(1):85-91.
49. Kilarski WW, Jura N, Gerwins P (2005) An ex vivo model for functional studies of myofibroblasts. Lab Invest 85(5):643-654. doi:10.1038/labinvest. 3700255. (Pubitemid 40675445)
50. Dellian M, Witwer BP, Salehi HA, Yuan F, Jain RK (1996) Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol 149:59-71. (Pubitemid 26230979)
51. Chen P, Guo M, Wygle D, Edwards PA, Falck JR, Roman RJ, Scicli AG (2005) Inhibitors of cytochrome P450 4A suppress angiogenic responses. Am J Pathol 166(2):615-624. doi:10.1016/S0002-9440(10)62282-1. (Pubitemid 40189056)
52. Sasaki T, Larsson H, Kreuger J, Salmivirta M, Claesson-Welsh L, Lindahl U, Hohenester E, Timpl R (1999) Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO 18:6240-6248. doi:10.1093/emboj/18.22.6240. (Pubitemid 29533228)
53. Oh SJ, Jeltsch MM, Birkenhäger R, McCarthy JE, Weich HA, Christ B, Alitalo K, Wilting J (1997) VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188: 96-109. doi:10.1006/dbio.1997.8639. (Pubitemid 27360090)
54. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3(5):349-363. (Pubitemid 34619269)
55. Kilarski WW, Gerwins P (2009) A new mechanism of blood vessel growth - hope for new treatment strategies. Discov Med 8:23-27.
56. Zijlstra A, Aimes RT, Zhu D, Regazzoni K, Kupriyanova T, Seandel M, Deryugina EI, Quigley JP (2004) Collagenolysisdependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3). J Biol Chem 279(26):27633-27645. (Pubitemid 38812605)
57. Folkman J, Ingber DE (1987) Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 206(3):374-383.
58. Gohongi T, Todoroki T, Fukumura D, Jain RK (2004) Influence of the site of human gallbladder xenograft (Mz-ChA-1) on angiogenesis at the distant site. Oncol Rep 11(4):803-807.